National Bank of Canada’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

National Bank of Canada’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$161K	Sell	2,425 -80	-3%	-$4.69K	﹤0.01%	1734
2026 Q1	$135K	Hold	2,505	–	–	﹤0.01%	1728
2025 Q4	$140K	Buy	2,505 +50	+2%	+$2.59K	﹤0.01%	1681
2025 Q3	$118K	Buy	2,455 +50	+2%	+$2.24K	﹤0.01%	1710
2025 Q2	$97.4K	Sell	2,405 -270	-10%	-$10.9K	﹤0.01%	1791
2025 Q1	$117K	Sell	2,675 -75	-3%	-$3.31K	﹤0.01%	1658
2024 Q4	$118K	Hold	2,750	–	–	﹤0.01%	1725
2024 Q3	$122K	Buy	2,750 +150	+6%	+$6.42K	﹤0.01%	1494
2024 Q2	$103K	Hold	2,600	–	–	﹤0.01%	1471
2024 Q1	$105K	Sell	2,600 -200	-7%	-$8.62K	﹤0.01%	1541
2023 Q4	$117K	Sell	2,800 -500	-15%	-$18.9K	﹤0.01%	1541
2023 Q3	$128K	Sell	3,300 -150	-4%	-$6.35K	﹤0.01%	1580
2023 Q2	$141K	Sell	3,450 -70	-2%	-$2.89K	﹤0.01%	1534
2023 Q1	$144K	Sell	3,520 -530	-13%	-$22.3K	﹤0.01%	1468
2022 Q4	$166K	Sell	4,050 -50	-1%	-$2.08K	﹤0.01%	1499
2022 Q3	$163K	Sell	4,100 -750	-15%	-$32.1K	﹤0.01%	1415
2022 Q2	$204K	Sell	4,850 -550	-10%	-$23.1K	﹤0.01%	1420
2022 Q1	$244K	Sell	5,400 -2,385	-31%	-$105K	﹤0.01%	1459
2021 Q4	$359K	Buy	+7,785	New	+$369K	﹤0.01%	1333

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

National Bank of Canada's XPH Position: Q2 2026 in Review

National Bank of Canada reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 3.2% in Q2 2026, selling an estimated $4.69K and leaving 2,425 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

National Bank of Canada first reported a position in XPH in Q4 2021 and has held it in 19 quarters since. The position peaked at $359K in Q4 2021. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

National Bank of Canada held 2,425 shares of State Street SPDR S&P Pharmaceuticals ETF worth $161K as of Q2 2026.
National Bank of Canada sold 80 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $4.69K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #1734 holding.
National Bank of Canada first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2021 and has held it in 19 quarters since.
National Bank of Canada's State Street SPDR S&P Pharmaceuticals ETF position peaked at $359K in Q4 2021.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.